CureVac

BioNTech
Manufacturing

BioNTech to exit several sites, impacting 1,800+ jobs

The German vaccine maker plans to wind down operations at a handful of its sites in Germany plus one in Singapore over 2027, impacting 1,860 jobs.
Zoey Becker May 5, 2026 11:36am
settlement lawsuit litigation

GSK nabs $320M in CureVac patent settlement

Aug 8, 2025 10:46am
BioNTech
Favicon Fierce Biotech

BioNTech buys German mRNA vaccine peer CureVac in $1.2B deal

Jun 12, 2025 8:17am
A gavel in the foreground with the scale of justice in the background

CureVac takes a legal loss as German court invalidates patent

Dec 19, 2023 1:36pm
CureVac

CureVac touts 'progress' in vaccine patent case against BioNTech

Sep 28, 2023 2:45pm
CureVac

CureVac expands COVID-19 patent cases against Pfizer, BioNTech

Jul 13, 2023 11:36am